V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012774 | 330004901 | 1.58 | 20.8 | Adjuvant (A) | 2015-10-05 | 2015-10-17 | Cyclophosphamide + Topotecan | 02 | N | 330014785 | CISPLATIN + DOXORUBICIN |
| 330012776 | 330004911 | 1.58 | 16.4 | Curative (C) | 2015-03-30 | 2015-03-30 | VAC | 2 | Y | 330014877 | CISPLATIN + ETOPOSIDE |
| 330012777 | 330004915 | null | 54 | null | 2014-06-08 | 2014-06-09 | Cisplatin + Doxorubicin | N | null | 330014897 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330012779 | 330004945 | 1.7 | 86.6 | Not known (9) | 2015-01-04 | 2015-04-02 | CISPLATIN + ETOPOSIDE | N | N | 330015116 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330012780 | 330004954 | 0 | 67.4 | Palliative (P) | 2015-01-12 | 2015-01-26 | Docetaxel 75mg/m2 (21 day) | N | null | 330015173 | DOCETAXEL |
| 330012781 | 330004958 | 1.71 | 79 | Palliative (P) | 2016-11-04 | 2016-11-04 | Temozolomide 150mg/m2 | N | N | 330015177 | VINBLASTINE |
| 330012782 | 330004963 | 1.6 | 71 | Curative (C) | 2015-03-08 | 2015-03-25 | CNS Low Grade Glioma Vinblastine | N | null | 330015195 | DA |
| 330012783 | 330004973 | null | 68 | Curative (C) | 2018-06-18 | 2018-06-18 | FLAG + Idarubicin | 02 | N | 330015345 | FLAG + IDARUBICIN |
| 330012784 | 330008719 | 1.66 | 75.3 | Palliative (P) | 2013-11-10 | 2013-11-10 | Irinotecan + Temozolomide | N | N | 330015523 | IRINOTECAN + TEMOZOLOMIDE |
| 330012785 | 330004993 | 1.59 | null | Palliative (P) | 2017-11-15 | 2017-11-18 | Cytarabine High Dose | 02 | N | 330015651 | CYTARABINE HIGH DOSE |
| 330012786 | 330010736 | null | 89 | Curative (C) | 2015-04-16 | 2015-06-25 | Cyclophosphamide + Topotecan | N | N | 330015848 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012787 | 330005010 | 0 | null | Palliative (P) | 2013-11-13 | 2013-11-17 | Cytarabine High Dose | 02 | N | 330015927 | CYTARABINE HIGH DOSE |
| 330012788 | 330010739 | 1.73 | 52.2 | Palliative (P) | 2013-11-04 | 2014-08-16 | CNS Low Grade Glioma Vinblastine | 2 | N | 330015927 | VINBLASTINE |
| 330012789 | 330005022 | null | 89.8 | Palliative (P) | 2017-03-11 | 2017-03-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330015996 | DOCETAXEL |
| 330012790 | 330005030 | 1.75 | 112 | null | 2014-11-02 | 2014-12-07 | VAC | N | null | 330016049 | VINBLASTINE |
| 330012791 | 330005039 | 1.61 | null | Disease modification (D) | 2019-03-25 | 2019-03-26 | Cyclophosphamide + Topotecan | 2 | N | 330016168 | DA |
| 330012792 | 330005050 | 0 | 64.6 | Palliative (P) | 2016-08-30 | 2017-03-04 | Methotrexate intrathecal | N | N | 330016238 | METHOTREXATE INTRATHECAL |
| 330012793 | 330005062 | null | 69 | Palliative (P) | 2018-10-22 | 2019-01-08 | Cisplatin + Doxorubicin | 01 | null | 330016340 | CISPLATIN + DOXORUBICIN |
| 330012794 | 330008781 | 0.95 | 64.75 | Palliative (P) | 2016-05-31 | 2016-09-23 | Azacitidine | 2 | N | 330016671 | VINBLASTINE |
| 330012795 | 330005110 | 1.76 | 54.4 | Palliative (P) | 2018-03-21 | 2018-06-18 | ETOPOSIDE | null | Y | 330016923 | ETOPOSIDE |
| 330012796 | 330008797 | 1.65 | 19.6 | Palliative (P) | 2014-05-08 | 2014-05-08 | EP 1 2 or 3 day | N | N | 330016960 | DA |
| 330012797 | 330005119 | 1.68 | null | Palliative (P) | 2014-06-23 | 2014-06-24 | Irinotecan + Temozolomide | 02 | N | 330016972 | IRINOTECAN + TEMOZOLOMIDE |
| 330012798 | 330005124 | 1.64 | 65.1 | Palliative (P) | 2017-12-21 | 2017-12-31 | FLAG + Idarubicin | 2 | N | 330017013 | FLAG + IDARUBICIN |
| 330012799 | 330010768 | null | 0 | Palliative (P) | 2015-11-29 | 2016-02-26 | GemCarbo Days 1+8 | 2 | N | 330017052 | GEMCARBO |
| 330012800 | 330013319 | 1.74 | 66 | Palliative (P) | 2013-12-18 | 2013-12-18 | Cytarabine High Dose | N | N | 330017086 | CYTARABINE HIGH DOSE |
| 330012801 | 330005141 | 0 | 61.85 | Palliative (P) | null | 2016-04-08 | FLAG + Idarubicin | N | N | 330017162 | FLAG + IDARUBICIN |
| 330012803 | 330005158 | 1.79 | 74.7 | Palliative (P) | 2015-01-05 | 2015-02-09 | Capecitabine (14 days)+Carboplatin | 02 | N | 330017337 | SUNITINIB |
| 330012804 | 330008828 | 1.6 | 63.85 | Curative (C) | 2015-04-11 | 2015-04-17 | Cisplatin + Fluorouracil + RT 5day | N | Y | 330017544 | DABRAFENIB + TRAMETINIB |
| 330012806 | 330005203 | null | 61.7 | Curative (C) | 2016-04-30 | 2017-03-12 | Capecitabine (14 days)+Carboplatin | N | null | 330017807 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 330012807 | 330008840 | 1.72 | 58.6 | Curative (C) | 2018-06-01 | 2018-07-24 | VIDE | N | null | 330017809 | CARBOPLATIN + DOCETAXEL |
| 330012808 | 330005210 | 1.56 | 55.75 | Palliative (P) | null | 2017-10-03 | CYCLOPHOSPHAMIDE | N | N | 330017874 | FLUOROURACIL |
| 330012809 | 330011879 | 0 | 67.8 | Palliative (P) | 2016-08-03 | 2017-02-25 | CTD Attenuated (Thalidomide 50mg) | Y | N | 330018009 | IFOSFAMIDE |
| 330012810 | 330005246 | 1.71 | 96 | Curative (C) | 2016-09-18 | 2016-09-24 | PONATINIB | N | N | 330018401 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330012811 | 330005269 | 0 | 61.1 | Neo-adjuvant (N) | 2017-12-26 | 2018-03-15 | VINCRISTINE | 1 | null | 330018777 | CAPECITABINE + VINORELBINE |
| 330012812 | 330005293 | 0 | 78.3 | null | 2017-08-30 | 2017-12-26 | AML17 TRIAL | N | N | 330018990 | UKALL2014 |
| 330012813 | 330008886 | null | 38.9 | Curative (C) | 2017-08-26 | 2018-06-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 330019079 | CYTARABINE + MITOXANTRONE |
| 330012814 | 330005313 | 1.67 | 58 | Palliative (P) | 2015-08-14 | 2015-10-13 | Cladribine IV (5 day) | null | N | 330019378 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 330012815 | 330011894 | 1.7 | 10.8 | Palliative (P) | 2014-04-27 | 2014-04-27 | Sunitinib | N | N | 330019528 | TRIPLE INTRATHECAL |
| 330012817 | 330005335 | 1.8 | null | Palliative (P) | 2015-04-28 | 2015-04-28 | CAPECITABINE + CARBOPLATIN + Cetuximab | 2 | null | 330019624 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330012818 | 330005341 | 1.81 | 0 | Palliative (P) | 2016-05-24 | 2016-05-25 | Doxorubicin + Methotrexate | 02 | N | 330019639 | THALIDOMIDE |
| 330012820 | 330005360 | null | 39.3 | Adjuvant (A) | 2016-03-02 | 2016-03-05 | MA (Cytarabine 3g/m2) | 2 | N | 330019771 | PEMBROLIZUMAB |
| 330012821 | 330005365 | 1.72 | null | Palliative (P) | 2013-12-03 | 2013-12-09 | Cladribine (subcut) 5 days | 2 | N | 330019784 | CARBOPLATIN + PEMETREXED |
| 330012822 | 330011901 | 1.71 | 62.6 | Palliative (P) | 2015-05-20 | 2015-05-23 | CVP R | N | N | 330019807 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 330012823 | 330010840 | 1.38 | 87 | Curative (C) | 2014-08-18 | 2014-08-22 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 330019906 | IPO |
| 330012824 | 330005387 | 1.64 | 70.2 | Curative (C) | null | 2014-02-10 | ALL UKALL2011 Consolidation A | Y | N | 330019979 | BORTEZOMIB + THALIDOMIDE |
| 330012825 | 330008937 | 1.85 | 64.1 | Curative (C) | 2016-06-14 | 2016-07-12 | UKALL14- Cons Cycle 1 | N | N | 330020045 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 330012826 | 330008945 | 1.79 | 65 | Palliative (P) | 2015-10-02 | 2015-10-02 | Capecitabine + Cisplatin | 02 | N | 330020179 | BCG |
| 330012827 | 330005410 | 0 | null | Palliative (P) | 2017-02-24 | 2017-02-25 | ALL Int Guide A/B/C Maint Ph V | 02 | null | 330020208 | GEMCITABINE |
| 330012828 | 330011907 | 1.78 | 38.9 | Curative (C) | 2015-08-04 | 2015-08-25 | CHLORAMBUCIL + RITUXIMAB | N | N | 330020236 | CHOP R |
| 330012829 | 330005442 | null | 8.6 | null | 2018-11-15 | 2018-11-15 | Depocyte Intrathecal | 02 | N | 330020433 | EPIRUBICIN |